Powering smarter, faster clinical trials
ObvioHealth (obviohealth.com) earns a Brand Analyzer score of 61 out of 100, placing it in the Developing tier among Healthcare brands, SaaS brands. Among 2305 Healthcare brands analyzed, ObvioHealth ranks in the 17th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 85/100, Digital Presence 35/100, Visual Identity 96/100, Messaging Clarity 95/100, Trust Foundation 53/100, AI Discoverability 90/100, Brand Authority 23/100.
ObvioHealth is a healthcare SaaS company based in New York, United States, that develops and operates ObvioGo®, an enterprise digital platform for hybrid and decentralized clinical trials. The platform is designed to simplify study design, improve participant engagement, and deliver real-time, compliant data. ObvioHealth serves clinical trial sponsors and research teams seeking agile, scalable solutions for conducting modern decentralized and hybrid trials.
| Brand Name | ObvioHealth |
|---|---|
| Domain | obviohealth.com |
| Industry | Healthcare, SaaS |
| Headquarters | New York, United States |
| Main Competitors | Medidata Solutions, Oracle Health Sciences (Oracle Clinical One) (88/100), Veeva Systems (81/100), Science 37, Medable, Thread (71/100) |
Moz Domain Authority 26/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "ObvioHealth powers smarter, faster clinical trials with ObvioGo®-an enterprise digital platform for hybrid and decentralized research." (Meta description: 16 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 3 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, YouTube, Instagram; no detected presence on X (Twitter), Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
ObvioHealth scores 29/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
ObvioHealth has a weak AI-visibility profile at 29/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (54/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 26/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
ObvioHealth's main competitors include Medidata Solutions, Oracle Health Sciences (Oracle Clinical One) (88/100), Veeva Systems (81/100), Science 37, Medable. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: ObvioHealth official site
ObvioHealth and Oracle Health Sciences (Oracle Clinical One) are competitors in Healthcare. Brand Analyzer scores ObvioHealth at 61/100 and Oracle Health Sciences (Oracle Clinical One) at 88/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: ObvioHealth official site
ObvioHealth's primary product is ObvioGo®, an enterprise digital platform for hybrid and decentralized clinical trials. ObvioGo provides a seamless, end-to-end solution through one unified platform that includes intuitive tools for study design, participant engagement features, real-time data collection and delivery, and built-in compliance capabilities. The platform is designed to support agile and scalable decentralized and hybrid clinical research.
Sources: ObvioHealth official site
Popular alternatives to ObvioHealth include Medidata Solutions, Oracle Health Sciences (Oracle Clinical One) (88/100), Veeva Systems (81/100), Science 37, Medable. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: ObvioHealth official site
ObvioHealth is a healthcare SaaS company headquartered in New York, United States. It positions itself as a leader in reimagining digital clinical trials by combining advanced digital tools with proven clinical science. The company develops ObvioGo®, an enterprise-grade digital platform built to support hybrid and decentralized clinical research at scale.
Sources: ObvioHealth official site
ObvioHealth has limited AI-search visibility, scoring 29/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 51, recommendation 54). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: ObvioHealth official site
ObvioHealth powers hybrid and decentralized clinical trials through its ObvioGo® platform. The platform provides end-to-end digital trial capabilities through a single unified system, offering intuitive tools for study design, real-time data collection, participant engagement features, and built-in compliance. It is designed to help clinical trial sponsors and research teams conduct agile, scalable trials more efficiently while delivering cleaner and faster data.
Sources: ObvioHealth official site
ObvioHealth scores 54/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: ObvioHealth official site
ObvioHealth's platform is used by clinical trial sponsors, researchers, and clinical trial teams who are conducting hybrid and decentralized clinical trials. These users are typically organizations in the pharmaceutical, biotech, or clinical research space seeking scalable digital tools to manage study design, participant engagement, and data collection in a compliant and efficient manner.
Sources: ObvioHealth official site
ObvioHealth is known for its ObvioGo® platform, which is an enterprise digital solution for decentralized and hybrid clinical trials. The company is recognized for its next-generation approach to simplifying study design, enhancing participant engagement, and delivering real-time, compliant data. ObvioHealth positions itself as a leader in reimagining clinical trials through advanced digital tools combined with proven clinical science.
Sources: ObvioHealth official site
ObvioHealth can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: ObvioHealth official site
Ranked closest to ObvioHealth: Nest Genomics (61/100), MEI Solutions (61/100), OvertureXL (61/100), Geneo (61/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).